MedPath

Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section

Phase 4
Conditions
Postoperative Pain
Interventions
Registration Number
NCT02279628
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

The cesarean section is considered as a painful surgery during the post operative period. Mothers may need to move immediately after the surgery to take care of their babies. This may increase the risk of major pain and chronic pain. Thus, excellent postoperative analgesia is required so that mothers do not experience pain in caring for their baby. Currently, several techniques have been developed to manage postoperative pain related to c-section scar such as intrathecal morphine during spinal anesthesia or continuous pre-peritoneal wound infiltration. The comparison between anesthetic techniques has never been performed and it is still not know if the combination of intrathecal morphine plus continuous pre-peritoneal wound infiltration provide a synergistic or additional effect on pain relief.

Detailed Description

The aim of this study is to compare the efficacy of continuous wound infiltration versus intrathecal morphine for postoperative analgesia after scheduled cesarean section. The primary endpoint is morphine consumption during the first 48 postoperative hours.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
150
Inclusion Criteria
  • Elective Cesarean section
  • Spinal anesthesia
  • Singleton
  • ASA ( Physical status score) 1 to 3
Exclusion Criteria
  • Age <18yrs
  • BMI ≥ 45 kg/m2 or weight < 45 kg
  • Refusal to consent
  • Urgent cesarean section
  • Allergy to a medication used in the protocol
  • Impaired hemostasis ou current infection
  • Contra indication or failure of spinal anesthesia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Continuous wound infiltration aloneRopivacaineSpinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 1 ml sodium chloride 0.9% (without morphine). Patient will then receive a continuous wound infiltration of ropivacaine 0.2% 8 ml/H via a preperitoneal catheter.
Intrathecal morphine&wound infiltrationMorphineSpinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 0.1mg morphine. Patient will then receive a continuous wound infiltration of ropivacaine 0.2% 8 ml/H via a preperitoneal catheter.
Intrathecal morphine&wound infiltrationRopivacaineSpinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 0.1mg morphine. Patient will then receive a continuous wound infiltration of ropivacaine 0.2% 8 ml/H via a preperitoneal catheter.
Intrathecal moprhine aloneMorphineSpinal anesthesia will be performed with 10 mg bupivacain 0.5% hyperbaric, 3 μg sufentanil and 0.1mg morphine. Patient will then receive a continuous wound infiltration of sodium chloride 0.9% 8 ml/H via a preperitoneal catheter.
Primary Outcome Measures
NameTimeMethod
Morphine consumption during the first 48 postoperative hoursat the 48th hour
Secondary Outcome Measures
NameTimeMethod
Time to restoration of bowel functionwithin the first 48 postoperative hours
Pain at rest and at mobilizationEvery 4 hours during the first 48 postoperative hours

The pain at rest and at mobilization will be evaluated with both Visual Analog scale and Verbal pain scale. The patient should describe the worst pain felt during the previous 4 hours in a lying position and at mobilization

Postoperative rehabilitation surveyAt the 48th hour
Verbal and Visual analog pain scores in the first standing positionat day 1
Number of patients that required oral morphineAt the 24th and 48th hour
Number of patients that required local anesthetic rescue dose through the catheterAt the 24th and 48th hour
Occurrence of side effectDuring the first 48 hours

Itching, nausea and vomiting, drowsiness, urinary retention, hypoventilation, other will be assessed with a questionnaire

Postoperative residual pain (DN4 survey)At 3 months postoperatively

Trial Locations

Locations (1)

Maternité Régionale Universitaire (MRU)

🇫🇷

Nancy, Lorraine, France

© Copyright 2025. All Rights Reserved by MedPath